High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?
Chitturi KR, Zhang C, Abusnina W, Sawant V, Banerjee A, Ahmed S, Merdler I, Haberman D, Chaturvedi A, Lupu L, Reddy P, Case BC, Rogers T, Hashim HD, Ben-Dor I, Bernardo NL, Satler LF, Waksman R.
Chitturi KR, et al. Among authors: bernardo nl.
Cardiovasc Revasc Med. 2024 Jul 14:S1553-8389(24)00580-3. doi: 10.1016/j.carrev.2024.07.003. Online ahead of print.
Cardiovasc Revasc Med. 2024.
PMID: 39013705